Earnings
Elevance Health (ELV) Falls Short of Expectations with Q2 ’25 Results
Elevance Health reported a 14.3% increase in operating revenue for Q2 2025, although earnings per share fell short of expectations.
Total Stories
7
News
ELV
Section
ELV
Earnings
Elevance Health (ELV) Delivers Q3 Results Above Expectations, Reaffirms 2025 Guidance
Elevance Health reported Q3 revenue of $50.1 billion and adjusted EPS of $6.03, exceeding expectations and reaffirming its full-year outlook.
Earnings
Elevance Health Reports Better than Expected Results for Q1 2025
Elevance Health reports a 15% revenue increase in Q1 2025, driven by growth across various segments.
Earnings
Elevance Health (NYSE: ELV) Falls to Deliver on EPS Expectations for Third Quarter
Elevance Health Inc. (NYSE: ELV) reported its third-quarter performance in 2024 with an operating revenue of $44.7 billion.
Earnings
Elevance Health Beats Expectations with $43.2 B in Q2 Operating Revenue
Elevance Health reported a stable second quarter 2024 performance, with operating revenue slightly decreasing to $43.2 billion.
Earnings
Elevance Health (ELV) Beats EPS Expectations at $10.64 in Q1, Revenue Miss
Elevance Health, Inc. (NYSE: ELV) showcased strategic advancements with operating revenue reaching $42.3 billion in the Q1.
Earnings
Elevance Health (ELV) Surpasses Expectations with $42.5B Revenue in Q4
Elevance Health, Inc. (NYSE: ELV) outperformed market expectations in Q4, with a reported adjusted diluted EPS of $5.62